Bio-Works Technologies
Bio-Works Receives SEK 5.5 Million Order from Global Pharmaceutical Company
The customer, who has previously used WorkBeads affimAb in several commercial processes, has placed this repeat order as a strong sign of continued confidence in Bio-Works’ products. The order reinforces the ongoing collaboration between the two companies and lays the foundation for a deeper long-term partnership.
WorkBeads affimAb is designed for efficient and selective purification of antibodies and is a highly attractive solution for industrial-scale biopharmaceutical production.
“Receiving a repeat order from a global pharmaceutical leader is a clear validation of our products’ performance in demanding, large-scale processes. It confirms our strategy to be an innovative and trusted partner in biopharmaceutical manufacturing,” says Lone Carlbom, CEO of Bio-Works Technologies AB.
This order reflects Bio-Works’ continued growth and strengthens the company’s position as a strategic supplier to the global biopharmaceutical industry.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 11-07-2025 15:28 CET.
| Datum | 2025-07-11, kl 15:28 |
| Källa | Cision |
200 kr till alla nya kunder! Just nu får alla nya kunder på Nordnet 200 kronor insatta i fonden Nordnet One Offensiv. Erbjudandet gäller mellan 1:e och 30:e september!